Home Shopping Network (HSN) is an American broadcast, basic cable and satellite television network that is owned by Qurate Retail Group, which also owns catalog company Cornerstone Brands. Based in St. Petersburg, Florida, the home shopping channel has former and current sister channels in several other countries. HSN also has an online outlet at HSN.com
Pfizer Oncology is committed to the discovery, investigation and development of innovative treatment options to improve the outlook for cancer patients worldwide. Our strong pipeline of biologics and small molecules, one of the most robust in the industry, is studied with precise focus on identifying and translating the best scientific breakthroughs into clinical application for patients across a wide range of cancers. By working collaboratively with academic institutions, individual researchers, cooperative research groups, patients, governments, and licensing partners, Pfizer Oncology strives to cure or control cancer with breakthrough medicines, that deliver the right drug for each patient at the right time. For more information, please visit www.Pfizer.com.
QVC, Inc., a wholly owned subsidiary of Liberty Interactive Corporation (NASDAQ: QVCA, QVCB), is the world's leading video and ecommerce retailer. QVC is committed to providing its customers with thousands of the most innovative and contemporary beauty, fashion, jewelry and home products. Its programming is distributed to approximately 340 million homes worldwide through operations in the U.S., Japan, Germany, United Kingdom, Italy, France and a joint venture in China. Based in West Chester, Pa. and founded in 1986, QVC has evolved from a TV shopping company to a leading ecommerce and mobile commerce retailer. The company's website, QVC.com, is ranked among the top general merchant Internet sites. QVC, Q, and the Q Ribbon Logo are registered service marks of ER Marks, Inc. www.qvc.com
In 2018 Servier opened the Servier Bioinnovation office and launched Servier Pharmaceuticals, the spearhead of the Group’s commercial activity in the United States. These new ventures signify a major step forward for Servier’s intention of establishing a long-lasting position in the country. They represent a twofold strategic objective for the Group: to treat even more patients with innovative medicines throughout the world and to become a leading global player in oncology. For more information, please visit www.servier.com